Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Cash from Financing Activities (2021 - 2025)

Valion Bio has reported Cash from Financing Activities over the past 5 years, most recently at $11.6 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 887.35% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $18.3 million, up 323.52%, while the annual FY2025 figure was $18.3 million, 323.52% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $11.6 million at Valion Bio, up from $4.3 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $14.9 million in Q4 2021 and troughed at -$584000.0 in Q4 2022.
  • A 5-year average of $3.0 million and a median of $1.4 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 103.92% in 2022 and later skyrocketed 7627.27% in 2024.
  • Year by year, Cash from Financing Activities stood at $14.9 million in 2021, then tumbled by 103.92% to -$584000.0 in 2022, then soared by 850.17% to $4.4 million in 2023, then plummeted by 73.11% to $1.2 million in 2024, then soared by 887.35% to $11.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for TIVC at $11.6 million in Q4 2025, $4.3 million in Q3 2025, and $2.4 million in Q2 2025.